Lupus erythematosus, drug-induced

L12_LUPUS_ADVERSE

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital discharge: ATC codes for adverse effects of drugs ANY
Hospital Discharge: ICD-10 L93#

1 out of 7 registries used, show all original rules.

7

diagram downward connector

Check minimum number of events None

7

diagram downward connector

Include endpoints None

7

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

6

diagram downward connector
L12_LUPUS_ADVERSE

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF5
Parent code in ICD-10 L80-L99
Name in latin Lupus erythematosus

Summary Statistics

Key figures

All Female Male
Number of individuals 6 5 -
Unadjusted prevalence (%) 0.00 0.00 -
Mean age at first event (years) 55.06 57.02 -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: L12_LUPUS_ADVERSE – Lupus erythematosus, drug-induced
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Lupus erythematosus, drug-induced

Endpoint not on priority list, no data to show.